Takeda Pharmaceutical Company Limited Settled Liabilities Contingent Liabilities Recognised In Business Combination
Takeda Pharmaceutical Company Limited (TKPHF) reported Settled Liabilities Contingent Liabilities Recognised In Business Combination of JPY 774.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination · last filed 2025-06-25
| Period end | Settled Liabilities Contingent Liabilities Recognised In Business Combination 12 month |
|---|---|
| 2025-03-31 | 774.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 9.03B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 728.00M JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 6.29B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 4.21B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 15.25B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 7.73B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 12.61B JPY 20-F · filed 2019-06-27 |